International Scientific Association for Probiotics and Prebiotics

The International Scientific Association for Probiotics and Prebiotics (ISAPP) is a non-profit organization dedicated to promoting the science behind probiotics and prebiotics. ISAPP participates in science-based written and oral communications and responds to emerging scientific issues regarding probiotics and prebiotics. The primary means through which ISAPP accomplishes its goals are annual meetings and follow up publications from that meeting.[1]

In addition, ISAPP collaborates with a number of related organizations (such as the American Gastroenterological Association, World Gastroenterology Organisation, National Academies of Sciences, International Life Sciences Institute of Europe and ILSI-North America, Harvard Division of Nutrition, Food Chemicals Codex and the New York Academy of Sciences) on common goals, such as sponsorship of meetings, preparation of probiotic and prebiotic usage guidelines, or preparation of position papers.

The business of ISAPP is conducted by a Board of Directors, currently composed of 10 globally recognized, academic scientists. In addition, an Executive Director and a representative from the ISAPP Industry Advisory Committee (IAC) are non-voting members of the board. Its source of revenue is from companies whose membership dues earn them a seat on the IAC.

All ISAPP activities are focused on science, not promotion of specific products. Industry scientists are invited to contribute their scientific ideas and participate in conferences, but no group or commercial entity directs ISAPP.

Probiotics and Prebiotics

Probiotics are live microorganisms, which when administered in adequate amounts confer a health benefit on the host.[2] A prebiotic is a selectively fermented ingredient that results in specific changes in the composition and/or activity of the gastrointestinal microbiota, thus conferring benefit(s) upon host health.[3]

Mission

To engender and disseminate information on high quality, multidisciplinary, scientific investigation in the fields of probiotics and prebiotics, and to advance the development of scientifically substantiated, health-promoting probiotic and prebiotic products worldwide.[4]

History

ISAPP was created in 2000 by a group of professional scientists at a Fermented Foods and Health Meeting in New York.[5] This group recognized the lack of an organization that brought together the multidisciplinary scientists from fields such as microbiology, medicine, nutrition, food science, immunology, biochemistry and nutrition, who are conducting research on probiotics and prebiotics. ISAPP was established as a 501(c)3 organization in August 2002. As of spring of 2011, ISAPP has held eight meetings, alternating between locations in North America and Europe. Over 30 papers have been published under the auspices of ISAPP, in numerous peer reviewed journals. The ISAPP organization also prepared guidelines for probiotic and prebiotic scientific standards.[6]

Membership in ISAPP

ISAPP is a member based organization, composed of companies and organizations with an interest in probiotics and prebiotics (known as the Industry Advisory Committee). The primary benefit of IAC membership is to provide input to the Board of Directors on emerging issues related to the industry, topics to address at the annual meeting and the opportunity to send up to two representatives to the annual meeting. The companies participating in ISAPP's IAC include the most scientifically committed and advanced probiotic and prebiotic companies globally. Under the current organizational structure, there is no mechanism for individual membership in ISAPP. The organization is run by its Board of Directors guided by bylaws, not by voting of individual members. There is no structure for collection of individual dues and there is no official ISAPP scientific journal. A working list of interested scientists is maintained, and this list is used to disseminate information relevant to the fields of probiotics and prebiotics.

Student and Fellows Association

In November 2009, the ISAPP Students and Fellows Association (ISAPP-SFA) was created to encourage graduate students and fellows conducting research in the probiotic and prebiotic fields an opportunity to interact with professionals in the field. The SFA functions to represent students and fellows to the board of directors of ISAPP as well as offer professional development opportunities to the members.[7]

Publications

Articles written by ISAPP, commissioned by the organization, or been produced after ISAPP annual meetings, have included the following topics: - Letter to the editor from ISAPP board members, expressing concerns over the way probiotic and prebiotic health claims on food are being assessed.[8]

- Other letters to the editor by the ISAPP board of directors on timely probiotic and prebiotic topics.[9][10][11][12]

- A summary of the Continuing Medical Education lecture series produced in conjunction with the American Gastroenterological Association, ILSI – North America, several industry sponsors and ISAPP.[13][14]

- A review on how probiotics and prebiotics can impact the immune system.[15]

- Providing probiotics and prebiotics to the developing world with the goal of improving health.[16]

- Perspectives from clinical physicians on conducting human research human studies with probiotics.[17]

- A review of prebiotics, advancing a new and improved definition of prebiotics.[18]

- Perspectives on what makes some people respond to probiotics but others not.[19]

- Probiotic safety.[20]

- How probiotics relate to the concept of the “hygiene hypothesis”.[21]

References

  1. ↑ Sanders ME. 2010. International Scientific Association for Probiotics and Prebiotics 2010 Meeting Report. Functional Food Reviews 2:131-140
  2. ↑ Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, October 2001; http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.
  3. ↑ Gibson et al. 2010. Food Science and Technology Bulletin: Functional Foods 7 (1) 1–19.
  4. ↑ ISAPP Website "About Us", 2011, http://www.isapp.net/about.asp
  5. ↑ Reid G. “Putting science first – The International Scientific Association for Probiotics and Prebiotics”. 2010. Functional Food Reviews. 2:124-130.
  6. ↑ ISAPP website, 2011, http://www.isapp.net/
  7. ↑ ISAPP Student and Fellows Association,2011, http://isapp-sfa.camp7.org/Default.aspx?pageId=499234
  8. ↑ Guarner F, Sanders ME, Gibson G, Klaenhammer T, Cabana M, Scott K, Reid G, Delzenne N, Fahey G, Hill C. Probiotic and prebiotic claims in Europe: seeking a clear roadmap. In Press. Brit J Nutr.
  9. ↑ Delzenne N, Reid G.No causal link between obesity and probiotics. Nat Rev Microbiol. 2009 Dec;7(12):901.
  10. ↑ Reid G, Gibson G, Sanders ME, Guarner F, Versalovic J. 2008. Probiotic prophylaxis in predicted severe acute pancreatitis. The Lancet 372:112-113.
  11. ↑ Sanders ME, Hamilton-Miller, J, Reid G, Gibson G. 2007. A non-viable preparation of L. acidophilus is not a probiotic. Clin Infect. Dis. 44:886.
  12. ↑ Tompkins TA, Sanders ME. 2004. Good intentions, poor study design. Can Fam Physician. 50:1499-500.
  13. ↑ The CME course: http://www.gastro.org/probiotics-and-prebiotics-webinars.
  14. ↑ Review paper: Wallace TC, Guarner F, Madsen K, Cabana M, Gibson G, Hentges E, Sanders ME. Human Gut Microbiota and Their Relationship to Health and Disease. In Press. Nutrition Reviews.
  15. ↑ O’Flaherty S, Saulnier D, Pot B, Versalovic J. “How can probiotics and prebiotics impact mucosal immunity? Gut Microbes”, 2010, http://www.landesbioscience.com/journals/30/article/12924/, 5/2/2011
  16. ↑ Monachese M, Cunningham-Rundles S, Diaz MA, Ermond E, Guerrant R, Hummelen R, Kemperman R, Kerac M, Kort R, Merenstein D, Panigrahi P, Ramakrishna B, Safdar N, Shane A, Trois L, Reid G. Probiotics and prebiotics to combat enteric diarrheal diseases and HIV in the developing world: a consensus report. In Press. Gut Microbes.
  17. ↑ Shane AL, Cabana M, Vidry S, Merenstein D, Hummelen R, Ellis CL, Heimbach JT, Hempel S, Lynch S, Sanders ME, Tancredi DJ. “Guide to designing, conducting, publishing, and communicating results of clinical studies involving probiotic applications in human participants”, 2010. “http://www.landesbioscience.com/journals/gutmicrobes/06-ShaneGUT1-4.pdf”, Gut Microbes 1:243-253.
  18. ↑ Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, Gareau M, Murphy EF, Saulnier D, Loh G, Macfarlane S, Delzenne N, Ringel Y, Kozianowski G, Dickmann R, Lenoir-Wijnkoop I, Walker C, Buddington R. 2010. Dietary prebiotics: Current status and new definition. IFIS Functional Foods Bulletin 7(1):1–19.
  19. ↑ Reid G, Gaudier E, Guarner F, Huffnagle GB, Macklaim J, Munoz AM, Martini M, Ringel-Kulka T, Sartor B, Unal R, Verbeke K, Walter J. 2010. Responders and non-responders to probiotic interventions: how can we improve the odds? Gut Microbes 1(3):1-5. Open access at: http://www.landesbioscience.com/journals/30/article/12013/
  20. ↑ Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach J, Huys G, Levy D, Mack D, Phothirath P, Constable A, Solano-Aguilar G, Vaughan E. “Assessment of probiotic safety for human use”, 2010, Gut Microbes 1 (3):1-22.
  21. ↑ Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA. 2006. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 3(5):275-84.

External links

This article is issued from Wikipedia - version of the Sunday, December 13, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.